Protease-activated receptor 2 drives migration in a colon cancer cell line but not in noncancerous human epithelial cells

Am J Physiol Gastrointest Liver Physiol. 2024 May 1;326(5):G525-G542. doi: 10.1152/ajpgi.00284.2023. Epub 2024 Mar 5.

Abstract

The inflamed mucosa contains a complex assortment of proteases that may participate in wound healing or the development of inflammation-associated colon cancer. We sought to determine the role of protease-activated receptor 2 (PAR2) in epithelial wound healing in both untransformed and transformed colonic epithelial cells. Monolayers of primary epithelial cells derived from organoids cultivated from patient colonic biopsies and of the T84 colon cancer cell line were grown to confluence, wounded in the presence of a selective PAR2-activating peptide, and healing was visualized by live cell microscopy. Inhibitors of various signaling molecules were used to assess the relevant pathways responsible for wound healing. Activation of PAR2 induced an enhanced wound-healing response in T84 cells but not primary cells. The PAR2-enhanced wound-healing response was associated with the development of lamellipodia in cells at the wound edge, consistent with sheet migration. The response to PAR2 activation in T84 cells was completely dependent on Src kinase activity and partially dependent on Rac1 activity. The Src-associated signaling molecules, focal adhesion kinase, and epidermal growth factor receptor, which typically mediate wound-healing responses, were not involved in the PAR2 response. Experiments repeated in the presence of the inflammatory cytokines TNF and IFNγ revealed a synergistically enhanced PAR2 wound-healing response in T84s but not primary cells. The epithelial response to proteases may be different between primary and cancer cells and is accentuated in the presence of inflammatory cytokines. Our findings have implications for understanding epithelial restitution in the context of inflammatory bowel disease (IBD) and inflammation-associated colon cancer.NEW & NOTEWORTHY Protease-activated receptor 2 enhances wound healing in the T84 colon cancer cell line, but not in primary cells derived from patient biopsies, an effect that is synergistically enhanced in the presence of the inflammatory cytokines TNF and IFNγ.

Keywords: Src kinase; colorectal cancer; epithelial wound healing; inflammation.

MeSH terms

  • Cell Line
  • Cell Movement
  • Colonic Neoplasms* / metabolism
  • Cytokines / metabolism
  • Epithelial Cells / metabolism
  • Humans
  • Inflammation / metabolism
  • Peptide Hydrolases / metabolism
  • Peptide Hydrolases / pharmacology
  • Receptor, PAR-2* / metabolism

Substances

  • Cytokines
  • Peptide Hydrolases
  • Receptor, PAR-2
  • F2RL1 protein, human